Effect of Cuminum cyminum on Metabolic Syndrome
Phase 3
- Conditions
- Metabolic syndrom.
- Registration Number
- IRCT20160308026971N7
- Lead Sponsor
- Rafsanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 66
Inclusion Criteria
Women aged 15-45
Use of contraceptive methods
Not pregnant
Having three of the five criteria for metabolic syndrome
Exclusion Criteria
Drug sensitivity
No drug intake for two consecutive days
Unwillingness to continue cooperation
Participate in sports classes
chronic disease
Weight loss diets
Alcoholism, tobacco and drugs abuse
Use of warfarin and heparin
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean concentration of fasting plasma glucose ? Triglyceride ?High Density Lipoprotein? Blood Pressure?Waist. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: The mean fasting plasma glucose concentration is based on the laboratory's response.Triglyceride is based on the laboratory's response. High Density Lipoprotein is a based on the laboratory's response.Hypertension is using a blood pressure monitor,The waist is measured using non-elastic bandwidth meter.
- Secondary Outcome Measures
Name Time Method